EUVIMEDEUVIMED entdecken
VergleichsstudieOpen Access · CC BY 4.0

Comparison of carbon ion radiotherapy and transarterial chemoembolization for unresectable solitary hepatocellular carcinoma >3 cm: a propensity score–matched analysis

Taito Fukushima iD, Satoshi Kobayashi, Hiroyuki Katoh, Tomomi Hamaguchi, Yuichiro Tozuka, Yasutsugu Asai, Shun Tezuka, Makoto Ueno, Manabu Morimoto, Junji Furuse, Shin Maeda

Journal of Radiation Research · 2025

DOI: 10.1093/jrr/rraf026 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Journal of Radiation Research, 2025. Verfasst von Taito Fukushima und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, Kanagawa Cancer Center, 2-3-2 Nakao, Asahi-ku, Yokohama, Kanagawa 241-8515, Japan. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Chemoembolization, Therapeutic, Liver Neoplasms, Propensity Score. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This study aimed to compare outcomes between carbon ion radiotherapy (C-ion RT) and transarterial chemoembolization (TACE) in patients with unresectable solitary hepatocellular carcinoma (HCC) >3 cm. Fifty-eight patients who had been treated with C-ion RT (C-ion RT group) and 34 treated with TACE (TACE group) were retrospectively enrolled between January 2016 and December 2021. Propensity score matching was conducted to account for differences between the two groups. The median follow-up duration was 42.1 months for all patients. Propensity score matching successfully balanced the two groups with 29 patients matched to each group. The 3-year overall survival (OS), progression-free survival (PFS) and local control (LC) rates in the C-ion RT vs TACE groups were 75.9% vs 45.4%, 44.8% vs 16.1% and 85.2% vs 23.2%, respectively. The C-ion RT group showed better OS (hazard ratio [HR], 0.578 [95% confidence interval (CI): 0.295–1.132]; P = 0.106), PFS (HR, 0.460 [95% CI: 0.254–0.835]; P = 0.009) and LC (HR, 0.155 [95% CI: 0.062–0.390]; P < 0.001) than the TACE group. Multivariate analysis indicated that C-ion RT was significantly associated with increased PFS (HR, 0.562 [95% CI: 0.341–0.926]; P = 0.024) and LC (HR, 0.282 [95% CI: 0.150–0.528]; P < 0.001). C-ion RT provided better OS, PFS and LC than TACE in patients with solitary HCC >3 cm. This study indicated that C-ion RT is a possible alternative to TACE, which is the standard of care for patients with medium-to-large-sized HCCs.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, HepatocellularChemoembolization, TherapeuticLiver NeoplasmsPropensity ScoreHeavy Ion RadiotherapyHumansMaleFemaleMiddle AgedAgedTreatment OutcomeRetrospective StudiesAdult

Stichwörter der Autor:innen

carbon ion radiotherapyhepatocellular carcinomapropensity scoresequential treatmentsystemic therapytransarterial chemoembolization

Autor:innen und Institutionen

  • Department of Gastroenterology, Kanagawa Cancer Center, 2-3-2 Nakao, Asahi-ku, Yokohama, Kanagawa 241-8515, Japan.
  • Division of Radiation Oncology, Kanagawa Cancer Center, 2-3-2 Nakao, Asahi-ku, Yokohama, Kanagawa 241-8515, Japan.
  • Gastroenterological Center, Yokohama City University Medical Center, 4-57 Urafune-cho, Minami-ku, Yokohama, Kanagawa 232-0024, Japan.
  • Department of Gastroenterology, Yokohama City University Graduate School of Medicine, 3-9 Fukuura, Kanazawa-ku, Yokohama, Kanagawa 236-0004, Japan.

ORCID-Profile: Taito Fukushima

Zitieren

APA

Fukushima, T., Kobayashi, S., Katoh, H., Hamaguchi, T., Tozuka, Y., Asai, Y., Tezuka, S., Ueno, M., Morimoto, M., Furuse, J., & Maeda, S. (2025). Comparison of carbon ion radiotherapy and transarterial chemoembolization for unresectable solitary hepatocellular carcinoma >3 cm: a propensity score–matched analysis. Journal of Radiation Research. https://doi.org/10.1093/jrr/rraf026

Vancouver

Fukushima T, Kobayashi S, Katoh H, Hamaguchi T, Tozuka Y, Asai Y, et al. Comparison of carbon ion radiotherapy and transarterial chemoembolization for unresectable solitary hepatocellular carcinoma >3 cm: a propensity score–matched analysis. Journal of Radiation Research. 2025. doi:10.1093/jrr/rraf026

BibTeX
@article{Fukushima2025,
  author = {Fukushima, Taito and Kobayashi, Satoshi and Katoh, Hiroyuki and Hamaguchi, Tomomi and Tozuka, Yuichiro and Asai, Yasutsugu and Tezuka, Shun and Ueno, Makoto and Morimoto, Manabu and Furuse, Junji and Maeda, Shin},
  title = {Comparison of carbon ion radiotherapy and transarterial chemoembolization for unresectable solitary hepatocellular carcinoma >3 cm: a propensity score–matched analysis},
  journal = {Journal of Radiation Research},
  year = {2025},
  doi = {10.1093/jrr/rraf026}
}
Kostenlos starten →